-
The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer
28 Mar 2024 13:57 GMT
… triple-negative breast cancer (TNBC) … Adrenocortical carcinoma; BC, Breast cancer; BLCA, Bladder Urothelial … Triple-negative breast cancer.
Data Sharing … paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients. Breast Cancer …
-
Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer
28 Mar 2024 13:57 GMT
… breast cancer, with 43,170 deaths attributed to breast cancer.1 Even more devastating, breast cancer … for breast cancer, … paclitaxel) for patients with unresectable locally advanced or metastatic triple-negative breast cancer … breast cancer. Breast Cancer Res …
-
Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates
29 Mar 2024 04:24 GMT
… well as toripalimab combined with paclitaxel and cisplatin for the first … for TUOYI® in combination with paclitaxel injection (albumin-bound) for the … or recurrent metastatic triple-negative breast cancer.
In June and August 2023 …
-
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
20 Mar 2024 19:10 GMT
… receptor-positive metastatic breast cancer.
“Although there have … alisertib plus paclitaxel versus paclitaxel alone have … receptor-positive metastatic breast cancer and in biomarker … -overexpressed/amplified breast cancer, following adjuvant trastuzumab …
-
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
20 Mar 2024 13:07 GMT
… receptor-positive metastatic breast cancer.
“Although there have … alisertib plus paclitaxel versus paclitaxel alone have … receptor-positive metastatic breast cancer and in biomarker … -overexpressed/amplified breast cancer, following adjuvant trastuzumab …
-
Tailoring Treatment, Personalized Care for Older Adult Patients With Advanced Breast Cancer
20 Mar 2024 12:41 GMT
Older adults living with advanced breast cancer represent a diverse patient population … -making among older adults with breast cancer while providing evidence-based recommendations … ) improves PFS and OS, but paclitaxel or endocrine therapy may be …
-
Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy
19 Mar 2024 14:20 GMT
… we established a large breast tumor model to evaluate the … Rh2, PTX, Lipusu® (paclitaxel liposome for injection), and Abraxane … tumors. Although only 4T1 breast tumors were tested as the … remodeling of triple-negative breast cancer by ginsenoside Rg3 based …
-
ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer
15 Mar 2024 09:12 GMT
… and ER+PR− breast tumors genetically different? A … transcriptomic architecture of 2000 breast tumours reveals novel subgroups. … profiles of 2433 breast cancers refine their genomic … confers paclitaxel resistance in erbB2-overexpressing breast cancer cells …
-
Machine learning and biological validation identify sphingolipids as key mediators of paclitaxel-induced neuropathy in cancer patients
19 Mar 2024 19:32 GMT
… enrolling patients with breast cancer. The study was … female with breast cancer and undergoing paclitaxel treatment were … connected with paclitaxel neurotoxicity and paclitaxel-induced neuropathy … with the “paclitaxel weekly” regimen (paclitaxel 80 mg…
-
SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer
08 Mar 2024 13:43 GMT
… the subset of breast cancers lacking expression of … transcriptomic architecture of 2000 breast tumours reveals novel subgroups. … of a 30-gene paclitaxel, fluorouracil, doxorubicin, and … (GLUD1) expression in breast cancer. Breast Cancer Res Treat. 2019;174 …